Arca
Skip to content
Tools
Tools

Precursor cell lymphoblastic leukemia-lymphoma

Drug research and approvals for precursor cell lymphoblastic leukemia-lymphoma: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 426 studies of precursor cell lymphoblastic leukemia-lymphoma are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 10 authorised medicines for it.

  • Recruiting worldwide: 426
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 10

Recruiting now

Newest posted first, of 426 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition or a subtype of it, from ChEMBL's drug indications

Approved 19

Phase 3 12 of 34

Phase 2 12 of 50

Phase 1 or earlier 12 of 69

How its trials ended

1,992 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 501 whose ending is known, 33% met their primary endpoint, 4% missed it and 63% stopped early.

  • Completed, result not reported62932%
  • Ongoing61331%
  • Status unknown24913%
  • Met its primary endpoint1668%
  • Stopped: other or unclear1578%
  • Stopped: enrollment or feasibility794%
  • Stopped: sponsor or business decision372%
  • Missed its primary endpoint211%
  • Stopped: lack of efficacy181%
  • Stopped: funding131%
  • Stopped: safety101%

Medicines authorised in the EU

Newest first
Jul 26, 2024Dasatinib Accord HealthcareDasatinib · genericAccord Healthcare S.L.U.EMA ↗
Sep 15, 2023EnrylazeCrisantaspaseJazz Pharmaceuticals Ireland LimitedEMA ↗
Jun 28, 2017BesponsaInotuzumab ozogamicin · orphanPfizer Europe MA EEIGEMA ↗
Jan 14, 2016OncasparPegaspargaseLes Laboratoires ServierEMA ↗
Jan 14, 2016SpectrilaAsparaginaseMedac Gesellschaft fuer klinische Spezialpraeparate mbHEMA ↗
Nov 23, 2015BlincytoBlinatumomab · orphanAmgen Europe B.V.EMA ↗
Jun 30, 2013Imatinib AccordImatinib · genericAccord Healthcare S.L.U.EMA ↗
Nov 20, 2006SprycelDasatinib (anhydrous)Bristol-Myers Squibb Pharma EEIGEMA ↗
May 29, 2006EvoltraClofarabineSanofi B.V.EMA ↗
Nov 7, 2001GlivecImatinibNovartis Europharm LimitedEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.